Merck & Co., Inc. Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less
Merck & Co., Inc. (MRK) reported Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less of -$197.00 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess · last filed 2011-05-09
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2011-03-31 was -$197.00M, a 107.52% decline year-over-year.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2010-12-31 was -$1.48B.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2010-09-30 was -$84.70M.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2010-06-30 was -$962.30M.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2010 was $90.00M.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2009 was -$2.42B, a 230.22% decline from fiscal 2008.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2008 was $1.86B, a 16215.79% increase from fiscal 2007.
- Merck & Co., Inc. proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2007 was $11.40M.
| Period end | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 3 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 3 month as first filed | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 6 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 9 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 12 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 12 month as first filed |
|---|---|---|---|---|---|---|
| 2011-03-31 | -$197.00M 10-Q · filed 2011-05-09 | -$1.68B derived: sum of 2 quarters · filed 2011-05-09 | -$1.76B derived: sum of 3 quarters · filed 2011-05-09 | -$2.73B derived: sum of 4 quarters · filed 2011-05-09 | ||
| 2010-12-31 | -$1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$1.57B derived: sum of 2 quarters · filed 2011-02-28 | -$2.53B derived: sum of 3 quarters · filed 2011-02-28 | $90.00M 10-K · filed 2011-02-28 | ||
| 2010-09-30 | -$84.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$1.05B derived: sum of 2 quarters · filed 2010-11-08 | $1.57B 10-Q · filed 2010-11-08 | $554.80M derived: sum of 4 quarters · filed 2011-05-09 | ||
| 2010-06-30 | -$962.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $1.66B 10-Q · filed 2010-08-06 | $639.50M derived: sum of 3 quarters · filed 2011-05-09 | -$978.60M derived: sum of 4 quarters · filed 2011-05-09 | ||
| 2010-03-31 | $2.62B 10-Q · filed 2011-05-09 | $2.62B 10-Q · filed 2010-05-07 | $1.60B derived: sum of 2 quarters · filed 2011-05-09 | -$16.30M derived: sum of 3 quarters · filed 2011-05-09 | -$313.70M derived: sum of 4 quarters · filed 2011-05-09 | |
| 2009-12-31 | -$1.02B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$2.64B derived: sum of 2 quarters · filed 2011-02-28 | -$2.93B derived: sum of 3 quarters · filed 2011-02-28 | -$2.42B 10-K · filed 2011-02-28 | ||
| 2009-09-30 | -$1.62B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$1.92B derived: sum of 2 quarters · filed 2010-11-08 | -$1.40B 10-Q · filed 2010-11-08 | |||
| 2009-06-30 | -$297.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $214.30M 10-Q · filed 2010-08-06 | ||||
| 2009-03-31 | $511.70M 10-Q · filed 2010-05-07 | |||||
| 2008-12-31 | $1.86B 10-K · filed 2011-02-28 | $1.86B 10-K · filed 2010-03-01 | ||||
| 2007-12-31 | $11.40M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |